PubRank

David Ghez

Author PubWeight™ 12.56‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Relationship between levels of indinavir in hair and virologic response to highly active antiretroviral therapy. Ann Intern Med 2002 2.05
2 Clinical and biological features of t(4;14) multiple myeloma: a prospective study. Leuk Lymphoma 2011 1.52
3 New therapeutic approaches for adult T-cell leukaemia. Lancet Oncol 2004 1.43
4 Case-control cohort study of patients' perceptions of disability in mastocytosis. PLoS One 2008 1.07
5 Phenotypic and genotypic characteristics of mastocytosis according to the age of onset. PLoS One 2008 0.98
6 Breakthrough Hormographiella aspergillata infections arising in neutropenic patients treated empirically with caspofungin. J Clin Microbiol 2010 0.87
7 Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis. Transfusion 2007 0.87
8 Diffuse large B-cell lymphoma in hyperimmunoglobulinemia E syndrome. Clin Lymphoma Myeloma 2007 0.85
9 Isolated splenic cat scratch disease. Clin Infect Dis 2003 0.79
10 Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia. Ann Hematol 2014 0.78
11 Antineutrophil cytoplasmic antibody-associated neutropenia. Eur J Intern Med 2004 0.77
12 Thalidomide in advanced mastocytosis. Br J Haematol 2008 0.76
13 MLL insertion with MLL-MLLT3 gene fusion in acute leukemia: case report and review of the literature. Cancer Genet Cytogenet 2008 0.75
14 Complete remission of a relapsing adult T cell leukaemia following treatment of a secondary acute promyelocytic leukaemia: towards a reappraisal of arsenic trioxide and all-transretinoic acid? BMJ Case Rep 2009 0.75
15 A double-blind low dose-finding phase II study of granulocyte colony-stimulating factor combined with chemotherapy for stem cell mobilization in patients with non-Hodgkin's lymphoma. Haematologica 2006 0.75
16 Dissociated responses to newer antimyeloma drugs identify a subset of refractory patients with an extremely poor prognosis. Eur J Cancer 2012 0.75
17 Reversible paraparesis in multiple myeloma with renal failure. Nephrol Dial Transplant 2006 0.75
18 Thalidomide-induced pneumonitis. Eur J Intern Med 2008 0.75